InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,312.18
(
0.08%
)
US TECH 100
18,186.60
(
-0.05%
)
Dow Jones
39,850.46
(
0.11%
)
Brent Oil
82.53
(
-1.20%
)
Bitcoin
70,017.09
(
-2.01%
)
Post# of 3834
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bradfor123

Send PM Follow Ignore
Followers 1
Posts 42
Boards Moderated 0
Alias Born 03/01/2014

bradfor123

Re: Tesla1 post# 814

Thursday, 04/03/2014 10:54:20 PM

Thursday, April 03, 2014 10:54:20 PM

Post# of 3834
Sofosbuvir from gilead which went passed and cleared fda in 6 monthstook at least 3 years to go from phase 2 to fda approval
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GALT News
More GALT News
InvestorsHub NewsWire

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Start posting your company's news
Only $200 per official company press release!